Scaffolds for tissue engineered hair

Abstract
Porous, bioabsorbable scaffolds for tissue engineering of human hair follicles, methods for their manufacture and methods of their use in creating new hair.
Description
BACKGROUND OF THE INVENTION

Male pattern baldness is a common condition that is often treated by hair transplant surgery. In this procedure hair follicles from areas of the scalp that are not within the baldness pattern are excised and re-implanted to create the illusion of a fuller head of hair. In fact, no new hair is created by this procedure, which is limited by the number of follicles that can be harvested for re-distribution. Thus, there is a great need, satisfied by the present invention, for a means for stimulating the growth of multiple new hair follicles in the scalp of an individual.


BRIEF SUMMARY OF THE INVENTION

This invention relates to new bioabsorbable scaffolds that are useful for the tissue engineering of new hair follicles and to methods for their manufacture and to methods of their use in creating new hair. More specifically it relates to new and useful bioabsorbable porous structures that have the correct architecture to facilitate culturing of the appropriate follicle progenitor cells and their development into normal, functional, hair-producing follicles. The invention also relates to methods of making and using bioabsorbable scaffolds to implant and grow new hair follicles in vitro and in vivo.





BRIEF DESCRIPTION OF THE DRAWING(S)


FIG. 1 is a cross-sectional view of form 1, with porous polymer precursor 5 coating the distal end 4 of form 1.



FIG. 2 is a cross-sectional view of porous scaffold 8 with a layer of follicle progenitor cells 9 lining the inner surface 10 of the porous scaffold.



FIG. 3 is a side, three-dimensional view of a non-woven web 12 of bioabsorbable porous polymer material.



FIG. 4 is a cross-sectional side view of a mold for forming a porous scaffold, comprising a top plate 14 having a bottom side 15 with forms 16 protruding from the bottom side of the top plate, and a bottom plate 17 with a top side 18 defining wells 19 designed to receive the forms 16 of the top plate 14, when aligned therewith.



FIG. 5 is a top, slightly raised view of the non-woven web 12′ after having been pressed and heated in the mold of FIG. 4, forming depressions 20 in the non-woven web.



FIG. 6 is a cross-sectional view of a set of scaffolds 10′, after transfer to wells 22 of a cell culture dish 23.





DETAILED DESCRIPTION OF THE INVENTION

In one aspect, the present invention comprises porous bioabsorbable scaffolds that are in the approximate shape of the normal hair follicle bulb, and designed to promote the formation of a hair follicle when seeded with hair follicle cells and implanted intradermally into a living host.


The scaffolds of the present invention are preferably comprised of a bioabsorbable polymer, selected from any of a wide variety of synthetic and natural polymers that are commonly used in clinical practice and in biomedical research. The scaffolds are more preferably comprised of a polymer selected from the group consisting of poly(lactic acid), poly(glycolic acid), poly(trimethylene carbonate), poly(amino acid)s, tyrosine-derived poly(carbonate)s, poly(carbonate)s, poly(caprolactone), poly(para-dioxanone), poly(ester)s, poly(ester-amide)s, poly(anhydride)s, poly(ortho ester)s, poly(amino acid)s, collagen, gelatin, serum albumin, proteins, carbohydrates, poly(ethylene glycol)s, poly(propylene glycol)s, poly(acrylate ester)s, poly(methacrylate ester)s, poly(vinyl alcohol), and copolymers, blends and mixtures of said polymers.


When the scaffold is comprised of a synthetic polymer, it is preferably a synthetic polymer formed from any one or combination of the following monomers: L-lactide, d,l-lactide, glycolide, trimethylene carbonate, caprolactone, and para-dioxanone. Other preferred synthetic polymers for use in making the scaffold of the present invention include poly(ethylene glycol), poly(vinyl alcohol), poly(acrylic acid) and other water soluble polymers that have been crosslinked with degradable linkages and any bioabsorbable hydrogel that has been modified to support cell attachment.


When the scaffold is comprised of a crosslinked or otherwise insoluble or insolubilized naturally occurring polymer, it is preferably a polymer selected from the group consisting of hyaluronic acid, human serum albumin, collagen, gelatin, cellulose derivatives, starch, dextrin, chitosan, and other proteins, glycoproteins, lipoproteins, polysaccharides, and biopolymers.


A preferred scaffold of the present invention has an inner surface which is preferably in the shape of the outer surface of a hair root or bulb. The inner surface of the scaffold is preferably porous. The porosity of the scaffold is preferably sufficient to enable hair follicle cells to be adsorbed by the inner surface of the scaffold when placed into contact therewith, e.g., in a cell culture solution.


Methods of making the porous bioabsorbable scaffolds of the present invention are disclosed herein, below. Such methods include procedures for creating porosity in bioabsorbable materials and procedures for molding, shaping, or sculpting said porous scaffolds into the desired configuration. The present invention is not limited to scaffolds produced according to the specific methods disclosed herein, below, as it is contemplated that the scaffolds could be made using variations of the disclosed methods, or by adapting known means used to manufacture porous polymers.


Any one of a number of different means are suitable for creating the porosity of the scaffolds of the present invention. A preferred method for creating porosity involves the use of “blowing agents”. These are chemical additives that decompose at known temperatures with the liberation of gases that cause foaming in the molten polymer and porosity in the resultant cooled material. A number of useful blowing agents are commercially available under the trade name of Celogen™ (Uniroyal Chemical Co.). One example of a traditional blowing agent is azodicarbonamide. Another blowing agent that may be especially useful in the present invention due to its compatibility with bioabsorbable polymers is urea dicarboxylic acid anhydride, described in U.S. Pat. No. 4,104,195, the teachings of which are incorporated herein. The use of blowing agents can produce both open cell and closed cell foams. In the present invention open cells are desired and closed cells are to be avoided. Thus the conditions used in the manufacture of the porous coating are preferably optimized to achieve an open cell structure known as “reticulated” foam. The porosity of the scaffold is preferably due to interconnected pores in the size range of 0.1 to 1,000 microns, more preferably in the size range of 1 to 500 microns.


In an alternative embodiment, the porosity of the scaffold is due to the fact that the scaffold has a fibrous structure. When the scaffold has a fibrous structure, the fibers are preferably bonded together. The fibers of such a preferred structure are more preferably comprised of a core and sheath structure, said sheath being lower melting than said core, and bonded together by means of inter-fiber welds in the sheaths at points of contact.


One preferred method of making a scaffold of the present invention, (hereinafter, “the dissolution method”) comprises the following steps:

  • 1. Provide a bioabsorbable polymer that is soluble in a solvent (solvent A).
  • 2. Provide a form in the shape of the desired scaffold made of a material that is soluble in a different solvent (solvent B) and that is substantially insoluble in solvent A.
  • 3. Coat the form with particles of a pore-forming substance that is also soluble in solvent B or in a third solvent (solvent C).
  • 4. Dissolve the bioabsorbable polymer in solvent A and apply the resultant solution to the particle-covered form.
  • 5. Remove solvent A by evaporation or other suitable means.
  • 6. Use solvent B to dissolve said form and said particles.
  • 7. Remove solvent B from the finished porous scaffold.
  • 8. If required, use solvent C additionally to remove said particles.


The dissolution method is illustrated in FIG. 1, which shows form 1 in cross-section with distal end 4 coated with porous polymer precursor 5, a mixture of particles of the pore forming substance and a solution of the polymer dissolved in solvent A. Note that the distal end 4 of form 1 is bulbous in shape, and includes a cavity 3 sufficiently large enough to enable some of the porous polymer precursor 5 to enter the cavity. Once a porous polymer has been formed from the porous polymer precursor 5 of FIG. 1, as described above, and the form has been dissolved, the resulting porous scaffold can be seeded with hair follicle progenitor cells and used as described below.



FIG. 2 is a cross-sectional view that shows the porous scaffold 8 obtained by dissolving and washing away the pore forming substance and form, as described above, leaving only the bioabsorbable polymer. The scaffold 8 is shown with follicle progenitor cells 9 seeded on to the inner surface 10 of the scaffold, having taken the shape of the scaffold. The structure shown in FIG. 2 could be directly implanted into the dermis to promote the growth of a new single hair fiber from the tissue engineered follicle. However, to better ensure that the transplanted engineered follicle matures, the structure shown in FIG. 2 is more preferably cultured with additional cells prior to implantation.


Examples of materials that can be used to create the form and solvents that can be selected for use as solvent B in the dissolution method, described above, include the following combinations: poly(ethylene oxide) and water; paraffin wax and hexane; and polystyrene and acetone. The pore forming substance and form material must be selected from those substances that have low solubility in solvent A, used to introduce the bioabsorbable polymer into the structure. These choices are further exemplified in Table 1 below where the following abbreviations have been used: PLGA is a copolymer of lactic and glycolic acids and PEO is poly(ethylene oxide).














TABLE 1





Bioabsorbable
Form
Pore forming
Solvent




polymer
material
substance
A
Solvent B
Solvent C







PLGA
PEO
Sodium
Acetone
Water
Water




chloride


PLGA
Wax
Glucose
Acetone
Hexane
Water


Collagen
Wax
Polystyrene
Water
Hexane
Acetone









A modification of the dissolution method is exemplified by reversing the sequence of steps of creating the desired structure followed by seeding with progenitor cells. Thus a porous scaffold structure can first be formed in the shape of a disc, for example by adding a solution of polymer in an organic solvent to appropriately sized salt particles in a cylindrical container followed by evaporation of said solvent and removal of the salt by dissolving and rinsing with water.


The resultant highly porous scaffold can then be sterilized and seeded with micro-dissected human dermal papilla or other suitable source of follicle progenitor cells and cultured in vitro until the entire porous structure is populated with cultured cells. This tissue-engineered construct then can be cut up into a large number of fragments, each about the size of a normal human dermal papilla. These irregular shaped fragments can be suspended in culture media and cultured further until the desired smooth surfaced structure is obtained. These tissue engineered dermal papilla can be implanted or injected into the skin to initiate the process of follicle neogenesis for hair restoration.


Alternatively, the porous scaffolds of the present invention can also be made according to the following method (hereinafter, the “pressed mold method”), comprising the following steps:


1. Provide a thin, non-woven web of bioabsorbable fibers.


2. Place said web in a two-part mold that has cavities in one part and mating forms in the other part, said cavities and forms providing the desired shape and dimensions of the desired scaffolds.


3. Close the mold and apply sufficient heat and pressure to form the web into the desired porous structure.


4. Remove the web from the mold and die-cut the molded scaffolds from the web.


The non-woven web preferably comprises either fibers that have a core/sheath structure in which the core of the fiber has a higher melting temperature than the sheath, or fibers without such a structure. The fibers in the non-woven web are preferably felted, sintered, or bonded with the use of a solvent or a second polymer dissolved in a solvent.



FIGS. 3–6 illustrate application of the mold method to produce scaffolds of the present invention. FIG. 3 shows a drawing of a non-woven web 12 of bioabsorbable fibers. FIG. 4 shows a two-part mold, comprising a top plate 14 and a bottom plate 17. The top plate features a bottom surface 15 with an array of forms 16 protruding therefrom. The bottom plate features a top surface 18 with depressions 19 therein to receive said forms. FIG. 5 is a slightly raised, angled view of the non-woven web 12′ after it has been compressed and heated in the mold of FIG. 4, thereby creating depressions 20 that are molded into the desired shape for scaffolds for tissue engineered hair. FIG. 6 shows molded scaffolds 8′ after they have been cut from the depressions 20 in the non-woven web 12′ in FIG. 5 by means of a die cutter, and transferred to wells 22 of culture dish 23. The wells 22 are designed to receive scaffolds 8 or 8′, culture medium, and cells.


The mold production process described immediately above is particularly well suited for scale-up and mass production. For example, the two-part mold shown in FIG. 4 could be produced in the form of two cylinders rather than two flat plates. The web, in the form of a continuous ribbon, could be embossed with the desired pattern as it is compressed and heated during passage between the two counter-rotating rolls. Die cutters also could be mounded in a rotating cylinder to cut out the scaffolds or the cutter could be an added feature of the embossing rolls. This automated assembly line process would continue with the scaffolds being deposited into cell culture wells that are pre-formed in polyester film. The scaffold-loaded film could be cut and packaged into trays, placed in additional packaging and sterilized.


Other methods of creating porous scaffolds from bioabsorbable materials also can be used in practice of the present invention. Methods such as emulsion freeze-drying, expansion in high pressure gas, 3D printing, and phase separation techniques are discussed in an article by Y. S. Nam and T. G. Park, “Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation”, The Journal of Biomedical Materials Research, October 1999, vol. 47, no. 1, pages 8–17, the teachings of which are incorporated herein.


A preferred embodiment of the above-mentioned phase separation technique uses poly(d,l-lactide-co-glycolide) (PLGA) as the structural polymer and poly(ethylene glycol) (PEG) as the porogen. Thus a mixture of PLGA and PEG can be dissolved in dichloromethane to give a clear solution, which is then applied to a scaffold form made from a material that is not soluble in dichloromethane, but preferably soluble in water, for example sugar. Upon evaporation of the dichloromethane, the PEG phase separates from the PLGA by crystallization. If the form is made of sugar, then soaking in water dissolves out the PEG as well as the form to leave the resultant desired porous PLGA scaffold.


Scaffolds of the present invention can be used to engineer new hair follicles in a number of ways. In general, the appropriate cells can be seeded on the scaffold and either implanted immediately into the scalp or allowed to multiply in culture on the scaffold prior to implantation. The implantation procedure can be the same technique that hair transplant surgeons currently use to implant single follicles or “mini-grafts”. For example, a laser can be used to bore a small hole in the scalp to precisely the desired depth and the cell-seeded scaffold can simply be planted in the hole. As these implanted cells grow they orchestrate the neo-genesis of a new hair follicle. The bioabsorbable scaffold then degrades and is eliminated from the site as the implant matures into a normal, hair-producing follicle.


The cells used to seed the scaffold can be taken from follicles biopsied from the patient or from organ donor follicles. This later option is known to be feasible due to recent research results. Follicle progenitor cells from a human donor were successfully transplanted into an unrelated human recipient where they initiated the formation of new follicles that grew hair. This finding, entitled “Trans-gender induction of hair follicles”, was reported by A. M. Reynolds, C. Lawrence, P. B. Caerhalmi-Friedman, A. M. Christiano and C. A. B. Jahoda in Nature, 402, 33–34, Nov. 4, 1999, the teachings of which are incorporated by reference herein. A distinct advantage of the present invention is the ability to multiply the cells in culture before seeding them on the scaffold implants. This both maximizes the number of scaffolds that can be seeded from each harvested follicle and minimizes the labor of dissecting follicles to obtain the desired progenitor cells.


EXAMPLES
Example 1

Poly(ethylene oxide) (hereinafter, “PEO”) 100,000 molecular weight purchased from Aldrich Chemical Co. (Milwaukee, Wis. 53201), was melt extruded into a 1.0 mm diameter filament and cut into 2 cm lengths. One of the PEO filaments was dipped into water, hydrating the surface and making it sticky. This was then dipped into sodium chloride crystals that had been ground into fine particles in an electric coffee bean grinder. Excess salt was shaken off and the coating was allowed to dry. A 10% (w/v) solution of poly(d,l-lactide-co-50%-glycolide) (PLGA) (Resomer RG504, Boehringer Ingelheim, Germany) in acetone (Aldrich Chemical Co.) was dripped onto the salt encrusted PEO filament and the excess solution was allowed to run off. Additional powdered salt was sprinkled onto the surface until it was completely covered. After the acetone evaporated, the coated PEO filament was placed in water until all of the salt and PEO dissolved, leaving a hollow filament of porous PLGA which was removed, flattened, and cut into thin strips with a sharp blade. The strips were rolled between finger and thumb and cut into 2 mm lengths. The hollow filament of porous PLGA produced as described above was used to make a form for a scaffold of the present invention, as follows.


Scaffolds of the present invention were produced as follows. A 0.3 mm diameter concentric hole was made in the end of another PEO filament by pressing a heated needle about 2 mm into the PEO. This caused molten PEO to build up around the sides of the filament. Upon cooling, the needle was removed. The hole was then filled with one of the above rolled strips of porous PLGA. The end of the resulting PEO filament was then coated as described above with salt and PLGA solution. Upon evaporation of the acetone and dissolving all of the salt and PEO in water and drying, the desired porous bioabsorbable polymer scaffold was obtained.


Example 2

Human hair follicles are dissected to obtain the dermal papilla, which are transferred to a culture flask containing culture media. After several weeks in culture, the dermal papilla cells multiply and grow over the surface of the cell culture flask. These cells are detached from the flask by treatment with an enzyme and concentrated by centrifugation. The cells are then transferred, after re-suspension, by pipette into the scaffolds of Example 1 and the cell-seeded scaffolds placed in a culture flask with media for several days to allow the cells to adhere to the surfaces of the scaffolds. Culturing of the cell-seeded scaffolds is then continued in another flask of media with gentle stirring until the scaffolds are fully populated with cells.


Example 3

Scaffolds seeded as described in Example 2 are implanted into the scalp of a human experiencing hair loss. Over time, as new hair follicles are created, new hairs grow from the implants, and the scaffolds bioabsorb.

Claims
  • 1. A porous scaffold comprising a bioabsorbable polymer and hair follicle progenitor cells; wherein the scaffold is about the shape of a hair follicle;wherein the porous scaffold comprises a fibrous structure; andwherein the fibrous structure comprises fibers that are bonded together.
  • 2. The scaffold of claim 1, in which the fibers comprise a core and a sheath, the sheath having a lower melting point than melting point of the core, and the fibers are bonded together by inter-fiber welds at at least one point of contact between the fibers.
  • 3. A method of making a porous scaffold comprising a bioabsorbable polymer and hair follicle progenitor cells, wherein the scaffold is about the shape of a hair follicle, comprising the steps of: a. providing a bioabsorbable polymer soluble in a first solvent;b. providing a form comprising a hair follicle shaped region and comprising a material soluble in a second solvent and substantially insoluble in the first solvent;c. coating the form with particles of a pore-forming substance soluble in the second solvent or in a third solvent;d. dissolving the bioabsorbable polymer in the first solvent and applying the dissolved polymer to the coated form;e. removing the first solvent;f. dissolving the form and the particles in the second solvent;g. removing the second solvent to form a scaffold; andh. seeding the scaffold with hair follicle progenitor cells.
  • 4. The method of claim 3, further comprising using the third solvent to remove the particles.
  • 5. A method of making a porous scaffold comprising a bioabsorbable polymer and hair follicle progenitor cells, wherein the scaffold is about the shape of a hair follicle, comprising the steps of: a. providing a bioabsorbable polymer soluble in a first solvent and substantially insoluble in a second solvent;b. providing a form comprising a hair follicle shaped region and comprising a material soluble in the second solvent and substantially insoluble in the first solvent;c. providing a pore-forming substance soluble in both the first and the second solvents;d. coating the form with a solution comprising the bioabsorbable polymer and the pore-forming substance dissolved in the first solvent;e. removing the first solvent and causing the pore-forming substance to phase separate from the bioabsorbable polymer;f. dissolving the form and the pore-forming substance with the second solvent;g. removing the second solvent to produce a porous scaffold; andh. seeding the scaffold with hair follicle progenitor cells.
  • 6. The method of claim 5, in which the bioabsorbable polymer comprises a copolymer of d,l-lactide and glycolide, the pore-forming substance comprises poly(ethylene glycol), the form comprises sugar, the first solvent comprises dichloromethane and the second solvent comprises water.
  • 7. A method of making a porous scaffold comprising a bioabsorbable polymer and hair follicle progenitor cells, wherein the scaffold is about the shape of a hair follicle, comprising the steps of: a. providing a thin, non-woven web of bioabsorbable fibers;b. placing the web in a two-part mold comprising a first part having cavities and a second part having mating forms, the cavities and mating forms together providing a hair follicle shaped region;c. closing the mold and applying sufficient heat and pressure to form the web into a porous structure; andd. removing the web from the mold;e. die-cutting the scaffold from the web;f. seeding the scaffold with hair follicle progenitor cells.
  • 8. A method of implanting hair follicle progenitor cells comprising implanting a porous scaffold comprising a bioabsorbable polymer and hair follicle progenitor cells into skin where growth of new hair is desired, wherein the scaffold is about the shape of a hair follicle.
  • 9. The method of claim 8, in which the progenitor cells are obtained from a substructure within a normal hair follicle.
  • 10. The method of claim 9, in which the progenitor cells are cultured prior to seeding the cells on the scaffold.
  • 11. The method of claim 9, wherein the substructure is selected from the group consisting of dermal papilla, dermal sheath and bulge area.
  • 12. The method of claim 8, in which the method of implantation of the scaffold is substantially equivalent to procedures used by hair transplant surgeons to implant single hair grafts into the skin.
Parent Case Info

This application claims priority to PCT/US01/24671 filed Aug. 7, 2001, which claims priority to U.S. Provisional Patent Application No. 60/223,636 filed Aug. 8, 2000, all of which are incorporated herein by reference.

PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/US01/24671 8/7/2001 WO 00 7/14/2003
Publishing Document Publishing Date Country Kind
WO02/15952 2/28/2002 WO A
US Referenced Citations (105)
Number Name Date Kind
2946769 Rose et al. Jul 1960 A
3025323 Rose et al. Mar 1962 A
3596292 Erb et al. Aug 1971 A
3966766 Lehn Jun 1976 A
4052988 Doddi et al. Oct 1977 A
4104195 Ley et al. Aug 1978 A
4209607 Shalaby et al. Jun 1980 A
4226243 Shalaby et al. Oct 1980 A
4242931 Clement Jan 1981 A
4343931 Barrows Aug 1982 A
4384061 Reiter et al. May 1983 A
4429080 Casey et al. Jan 1984 A
4458678 Yannas et al. Jul 1984 A
4505266 Yannas et al. Mar 1985 A
4529792 Barrows Jul 1985 A
4604097 Graves, Jr. et al. Aug 1986 A
4643734 Lin Feb 1987 A
4719917 Barrows et al. Jan 1988 A
4851521 della Valle et al. Jul 1989 A
4919664 Oliver et al. Apr 1990 A
5061284 Laghi Oct 1991 A
5091173 Buultjens et al. Feb 1992 A
5133739 Bezwada et al. Jul 1992 A
5141522 Landi Aug 1992 A
5147400 Kaplan et al. Sep 1992 A
5194473 Shinoda et al. Mar 1993 A
5198507 Kohn et al. Mar 1993 A
5286837 Barrows et al. Feb 1994 A
5393323 Simmons Feb 1995 A
5403347 Roby et al. Apr 1995 A
5415378 Craven May 1995 A
5423778 Eriksson et al. Jun 1995 A
5486593 Tang et al. Jan 1996 A
5502092 Suszko et al. Mar 1996 A
5514378 Cima et al. May 1996 A
5522841 Roby et al. Jun 1996 A
5545208 Wolff et al. Aug 1996 A
5556783 Lavker et al. Sep 1996 A
5578046 Liu et al. Nov 1996 A
5599552 Dunn et al. Feb 1997 A
5611811 Goldberg Mar 1997 A
5639645 Murata Jun 1997 A
5661132 Eriksson et al. Aug 1997 A
5667961 Bernard et al. Sep 1997 A
5674286 D'Alessio et al. Oct 1997 A
5677355 Shalaby et al. Oct 1997 A
5690961 Nguyen Nov 1997 A
5697901 Eriksson Dec 1997 A
5697976 Chesterfield et al. Dec 1997 A
5721049 Marcolongo et al. Feb 1998 A
5723508 Healy et al. Mar 1998 A
5756094 Lavker et al. May 1998 A
5770417 Vacanti et al. Jun 1998 A
5847012 Shalaby et al. Dec 1998 A
5898040 Shalaby et al. Apr 1999 A
5919893 Roby et al. Jul 1999 A
5939323 Valentini et al. Aug 1999 A
5945115 Dunn et al. Aug 1999 A
5993374 Kick Nov 1999 A
5997468 Wolff et al. Dec 1999 A
5997568 Liu Dec 1999 A
6001378 Desjonqueres Dec 1999 A
6027744 Vacanti et al. Feb 2000 A
6031148 Hayes et al. Feb 2000 A
6051750 Bell Apr 2000 A
6093200 Liu et al. Jul 2000 A
6120788 Barrows Sep 2000 A
6147135 Yuan et al. Nov 2000 A
6159950 Crystal et al. Dec 2000 A
6303697 Yuan et al. Oct 2001 B1
6333029 Vyakarnam et al. Dec 2001 B1
6350284 Tormala et al. Feb 2002 B1
6365172 Barrows Apr 2002 B1
6383220 van Blitterswijk et al. May 2002 B1
6423252 Chun et al. Jul 2002 B1
6436424 Vogel et al. Aug 2002 B1
6474344 Yamada Nov 2002 B2
6503539 Gestrelius et al. Jan 2003 B2
6511748 Barrows Jan 2003 B1
6569143 Alchas et al. May 2003 B2
6613798 Porter et al. Sep 2003 B1
6639051 Wang Oct 2003 B2
6660301 Vogel et al. Dec 2003 B1
6699287 Son et al. Mar 2004 B2
6773713 Bonassar et al. Aug 2004 B2
6884427 Barrows Apr 2005 B1
20020049426 Butler et al. Apr 2002 A1
20020083216 Hickson et al. Jun 2002 A1
20020193740 Alachas et al. Dec 2002 A1
20020193778 Alachas et al. Dec 2002 A1
20020197326 Vogel et al. Dec 2002 A1
20030009113 Olson Jan 2003 A1
20030072784 Williams Apr 2003 A1
20030077311 Vyakarnam et al. Apr 2003 A1
20030161815 Wolowacz et al. Aug 2003 A1
20030195625 Castro et al. Oct 2003 A1
20030203003 Nelson et al. Oct 2003 A1
20030208138 Olson Nov 2003 A1
20030211083 Vogel et al. Nov 2003 A1
20040033598 Vacanti et al. Feb 2004 A1
20040039438 Alt Feb 2004 A1
20040054410 Barrows Mar 2004 A1
20040057937 Jahoda et al. Mar 2004 A1
20040068284 Barrows Apr 2004 A1
20040096514 Vogel May 2004 A1
Foreign Referenced Citations (35)
Number Date Country
2140090 Aug 1995 CA
2199918 Sep 1997 CA
0236014 Sep 1987 EP
405656 Jan 1991 EP
1002859 May 2000 EP
971679 Jun 2002 EP
00845963 Sep 2003 EP
1083874 Jan 2004 EP
1089704 Feb 2004 EP
1098626 May 2004 EP
1437042 Jul 2004 EP
3273028 Dec 1991 JP
4-108444 Apr 1992 JP
7-48769 Feb 1995 JP
10-136977 May 1998 JP
2003328229 Nov 2003 JP
WO199962491 Jun 1998 WO
WO 9844027 Oct 1998 WO
WO199847471 Oct 1998 WO
WO 9934750 Jul 1999 WO
WO200003749 Jul 1999 WO
WO 0029553 May 2000 WO
WO 0045736 Aug 2000 WO
WO 0062829 Oct 2000 WO
WO200158413 Aug 2001 WO
WO200166472 Sep 2001 WO
WO200170132 Sep 2001 WO
WO200170289 Sep 2001 WO
WO200170290 Sep 2001 WO
WO200170291 Sep 2001 WO
WO2002060396 Aug 2002 WO
WO2002070728 Sep 2002 WO
WO2003022043 Mar 2003 WO
WO 03104443 Dec 2003 WO
WO2004044188 May 2004 WO
Related Publications (1)
Number Date Country
20040054410 A1 Mar 2004 US
Provisional Applications (1)
Number Date Country
60223636 Aug 2000 US